MedTrace Logo

Near Patient Molecular Testing in Sepsis

NCT05469048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2024-10-02

No results posted yet for this study

Summary

The purpose of the study is to evaluate the real-time performance of a new host response test (SeptiCyte RAPID) for differentiating sepsis from non-infection/systemic inflammatory response syndrome among patients suspected of sepsis within the first 24 hours of intensive care unit (ICU) admission.

Conditions

  • Sepsis
  • Systemic Inflammatory Response Syndrome

Sponsors & Collaborators

  • Rush University Medical Center

    collaborator OTHER

  • Grady Memorial Hospital

    collaborator OTHER

  • University of Southern California

    collaborator OTHER

  • Immunexpress

    lead INDUSTRY

Principal Investigators

  • Roy Davis, MD, PhD, MHA · Immunexpress

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-12
Primary Completion
2021-05-31
Completion
2022-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05469048 on ClinicalTrials.gov